| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 10/02/2013 | CN102335204B Chinese medicine Jinshuibao pill preparation and preparation method thereof |
| 10/02/2013 | CN102319204B Azithromycin ophthalmic preparation drug composition and preparation method thereof |
| 10/02/2013 | CN101983721B Desert cistanche calcium composition having functions of fatigue resistance and calcium supplement |
| 10/02/2013 | CN101754677B Method for preparing particles comprising metal oxide coating and particles with metal oxide coating |
| 10/02/2013 | CN101721634B Black corn extraction liquid |
| 10/02/2013 | CN101516403B Orally disintegrating tablet and process for production thereof |
| 10/02/2013 | CN101346128B Formulation comprising drug of low water solubility and method of use thereof |
| 10/01/2013 | US8547239 Methods for detecting failure states in a medicine delivery device |
| 10/01/2013 | US8546555 Cochleate compositions directed against expression of proteins |
| 10/01/2013 | US8546480 Relief printing plate precursor for laser engraving and method for producing relief printing plate |
| 10/01/2013 | US8546453 Propofol compositions and methods for reducing pain associated with propofol injection |
| 10/01/2013 | US8546372 Methods of treating hypertriglyceridemia |
| 10/01/2013 | US8546341 Compositions and methods for treating bruises |
| 10/01/2013 | US8546340 Soothing pharmaceutical or cosmetic composition comprising a peptide that activates HMG-CoA reductase |
| 10/01/2013 | US8546326 low viscosity mixture of: a) at least one neutral diacyl lipid, such as a diacyl glycerol; b) at least one phospholipid, such as a phosphatidyl choline; c) at least one biotolerable solvent, such as an oxygen containing solvent; d) at least one GLP-1 analogue; wherein the pre-formulation forms |
| 10/01/2013 | US8546306 Microcapsules comprising a lipophilic surfactant and oil |
| 10/01/2013 | US8546143 Compositions and methods for inhibiting expression of a target gene |
| 10/01/2013 | US8545892 Sustained release beads and suspensions including the same for sustained delivery of active ingredients |
| 10/01/2013 | US8545891 Sunscreen compositions having synergistic combination of titanium dioxide filters |
| 10/01/2013 | US8545890 Orally disintegrating tablets |
| 10/01/2013 | US8545889 Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms |
| 10/01/2013 | US8545888 Tendon stem cells |
| 10/01/2013 | US8545887 Modified release dosage forms |
| 10/01/2013 | US8545886 Extended release tablet formulations of flibanserin and method for manufacturing the same |
| 10/01/2013 | US8545885 Stable laquinimod preparations |
| 10/01/2013 | US8545884 Solid pharmaceutical formulations comprising BIBW 2992 |
| 10/01/2013 | US8545883 Modular systems for the controlled release of a substance with space and time control |
| 10/01/2013 | US8545882 Control release formulation containing a hydrophobic material as the sustained release agent |
| 10/01/2013 | US8545881 Orally disintegrating tablets and methods of manufacture |
| 10/01/2013 | US8545880 Controlled release oral dosage form |
| 10/01/2013 | US8545879 Fast disintegrating compositions of meloxicam |
| 10/01/2013 | US8545878 Capsules containing high doses of levodopa for pulmonary use |
| 10/01/2013 | US8545876 Modified drugs for use in liposomal nanoparticles |
| 10/01/2013 | US8545875 Nanolipidic particles |
| 10/01/2013 | US8545874 Method for making nanolipidic particles |
| 10/01/2013 | US8545873 Percutaneous absorption type plaster |
| 10/01/2013 | US8545872 Device for the transdermal administration of a rotigotine base |
| 10/01/2013 | US8545870 Medicinal table with prolonged release of the active principle |
| 10/01/2013 | US8545868 Drug eluting implantable medical device with hemocompatible and/or prohealing topcoat |
| 10/01/2013 | US8545864 Hemostatic bone graft |
| 10/01/2013 | US8545861 Tissue web treated with relatively low viscosity oil in water emulsion; easily be wet for excellent sinking behaviour in water; use as toilet paper |
| 10/01/2013 | US8545858 Porous calcium phosphate bone material |
| 10/01/2013 | US8545857 Compositions and methods for administering compartmentalized frozen particles |
| 10/01/2013 | US8545856 Compositions and methods for delivery of frozen particle adhesives |
| 10/01/2013 | US8545855 Compositions and methods for surface abrasion with frozen particles |
| 10/01/2013 | US8545832 Lipid depot formulations |
| 10/01/2013 | US8545830 Smart segment and a hydrophobic and a hydrophillic biodegradable segment which are hydrolytically or enzymatically degradable; prolonged delivery of therapeutic agents |
| 10/01/2013 | US8545829 Pharmaceutical preparations for oral administration, containing ion-exchange resins loaded with active ingredients and intrinsically viscous gelling agents as thickening agents |
| 10/01/2013 | US8545817 Cosmetic composition comprising at least one polysaccharide of λ-carrageenan type in aerosol form, method for the cosmetic treatment of keratinous fibers, and product comprising the composition |
| 10/01/2013 | US8545816 1-(4-methoxyphenyl)-vinyl 4-tert-butylbenzoate; cosmetic, pharmaceutical, personal care and industrial preparations as sunscreens; ultraviolet radiation protection |
| 10/01/2013 | US8545815 VOC-free compressed gas aerosol composition |
| 10/01/2013 | US8545806 Compositions and methods for biological remodeling with frozen particle compositions |
| 10/01/2013 | US8545550 Drug-delivery endovascular stent and method for treating restenosis |
| 10/01/2013 | US8545484 Accumulator for implantable infusion device |
| 10/01/2013 | US8545483 Physiological sensors with telemonitor and notification systems |
| 10/01/2013 | US8545482 Tissues patches and related delivery systems and methods |
| 10/01/2013 | CA2750626C High dosage doramectin formulation |
| 10/01/2013 | CA2737335C 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases |
| 10/01/2013 | CA2725329C Nanoemulsion vaccines |
| 10/01/2013 | CA2673924C Liposomal pharmaceutical preparation and method for manufacturing the same |
| 10/01/2013 | CA2655901C Collagen product for medical or cosmetic applications, method for the manufacture thereof and use thereof |
| 10/01/2013 | CA2642241C New stable hyperbaric composition comprising prilocaine hcl, use of said new composition for intrathecal anaesthesia, and method for manufacturing said composition |
| 10/01/2013 | CA2625532C Agent for applying to mucosa containing a hydrophobic group binding type glycosaminoglycan |
| 10/01/2013 | CA2617530C Method of producing nano- and microcapsules of spider silk protein |
| 10/01/2013 | CA2615912C Lotion preparation containing pyridonecarboxylic acid derivative |
| 10/01/2013 | CA2605839C Stabilized composition of a proton pump inhibitor |
| 10/01/2013 | CA2588465C Pharmaceutical composition containing an anti-nucleating agent |
| 10/01/2013 | CA2583562C Medicament and system for the percutaneous administration of medicaments |
| 10/01/2013 | CA2583332C Liposomal composition comprising an active ingredient for relaxing smooth muscle production and therapeutically use of said composition |
| 10/01/2013 | CA2582668C Nanoparticles comprising antigens and adjuvants, and immunogenic structures |
| 10/01/2013 | CA2579605C Topical compositions and methods for epithelial-related conditions |
| 10/01/2013 | CA2577361C Pharmaceutical composition in the form of a gastric-resident tablet containing an active principle |
| 10/01/2013 | CA2573386C Composition for promoting vascular smooth muscle relaxation |
| 10/01/2013 | CA2570960C Compositions and methods for treating central precocious puberty |
| 10/01/2013 | CA2567961C Superloaded liposomes for drug delivery |
| 10/01/2013 | CA2567532C Methods for making injectable polymer hydrogels |
| 10/01/2013 | CA2563533C Compositions capable of facilitating penetration across a biological barrier |
| 10/01/2013 | CA2557142C Method for providing antimicrobial composite yarns, composite fabrics and articles made therefrom |
| 10/01/2013 | CA2552241C Co-polymeric devices for controlled release of active agents |
| 10/01/2013 | CA2522625C Magnetically controllable drug and gene delivery stents |
| 10/01/2013 | CA2507769C Density-controlled particulate suspensions for foodstuff, cosmetic, pharmaceutical and other uses |
| 09/27/2013 | CA2784240A1 Stable bortezomib formulations |
| 09/26/2013 | WO2013142792A1 Stabilizing composition for biological materials |
| 09/26/2013 | WO2013142482A1 Gelling agent-based dosage form |
| 09/26/2013 | WO2013142374A1 Compositions and uses of antimicrobial materials with tissue-compatible properties |
| 09/26/2013 | WO2013142339A1 Transdermal therapeutic system and method |
| 09/26/2013 | WO2013142258A1 Compositions and methods for oral delivery of encapsulated diethylenetriaminepentaacetate particles |
| 09/26/2013 | WO2013142251A1 Cyclodextrin-based microemulsions, and dermatological uses thereof |
| 09/26/2013 | WO2013142249A1 Cyclodextrin-based microemulsions, and dermatological uses thereof |
| 09/26/2013 | WO2013142247A1 Cyclodextrin-based microemulsions, and dermatological uses thereof |
| 09/26/2013 | WO2013142197A1 Extended-release formulation for reducing the frequency of urination and method of use thereof |
| 09/26/2013 | WO2013142119A1 Silk reservoirs for drug delivery |
| 09/26/2013 | WO2013142018A1 Therapeutic skin lifting device and related systems and methods |
| 09/26/2013 | WO2013141827A1 Enteric coated solid pharmaceutical compositions for proton pump inhibitors |
| 09/26/2013 | WO2013141346A1 Method for producing liposome encapsulating paclitaxel monoglycoside and/or docetaxel monoglycoside |
| 09/26/2013 | WO2013140799A1 Transdermal absorption preparation |
| 09/26/2013 | WO2013140643A1 Carrier for intracellular delivery of functional protein |
| 09/26/2013 | WO2013140639A1 Tablet, method for producing tablets, tablet management device, tablet validation device, and program |
| 09/26/2013 | WO2013140300A1 Coloured solution in particular for use in surgical methods for the treatment of the bodies of humans or animals. |
| 09/26/2013 | WO2013140176A1 Skin dressing with electrodes and physiologically active precursor substance |